Aurobindo Pharma, one of the largest API manufacturers in Asia, on Wednesday received its first approval from Swissmedic, Government of Switzerland for the license of Finasteride APL Tablets 5mg.
The drug is generic equivalent of MERCK & CO., Inc's Proscar Tablet.
Finasteride APL Tablet 5mg is used alone or in combination with another medication to treat benign prostatic hypertrophy (BPH, enlargement of the prostate gland). The drug is seen very effective in symptoms of BPH such as frequent and difficult urination. In addition, it also may decrease the chance of needing prostate surgery.